The recent detection of H5N1 avian influenza in New Zealand has shed light on a critical gap in the country's insurance coverage, leaving many consequential losses unprotected. This issue, which has been a concern for brokers and underwriters, is now coming to the forefront as the government's cost-sharing framework is activated.
The Structural Gap
The confirmation of H5N1, a highly pathogenic strain, has exposed a structural deficiency in the current insurance market. While the Government Industry Agreement (GIA) outlines cost-sharing arrangements for poultry diseases, it fails to address the consequential losses that can arise from such events. This gap is particularly evident when comparing it to New Zealand's most recent HPAI incident in 2024, where the direct costs were estimated at $25 million, but the government had to approve additional funding to cover unbudgeted expenses.
What makes this particularly fascinating is the potential impact on the industry. With H5N1 carrying a more severe risk profile, the financial models built around previous outbreaks are now obsolete. The industry must now grapple with the reality of a potentially widespread outbreak in wild birds, which could lead to significant losses and a strain on resources.
Private Insurance Limitations
Private insurance companies, such as Lockton and Howden, have highlighted the limitations of their coverage. Bird flu insurance is often sub-limited and not readily available in all regions, especially given the severity of potential losses. This means that producers are advised to secure protection before an outbreak occurs, which is a challenging task when the risk is already present, as is the case in New Zealand.
In my opinion, this highlights a broader issue within the insurance industry. The nature of insurance is to provide coverage for unforeseen events, but when the risk is already known and present, the industry struggles to adapt. It raises questions about the effectiveness of insurance in such scenarios and the need for innovative solutions.
Regulatory Changes and Industry Impact
Additionally, the regulatory landscape is shifting, with MPI proposing new regulations for commercial poultry operators. These regulations will require operators to meet auditable biosecurity standards and bear partial costs for audits, potentially leading to some exiting the industry. This further compounds the issue, as the industry is already facing a tightening insurance market and the confirmed presence of H5N1 in wild birds.
The exposure base for the poultry industry is significant, with an estimated $2.2 billion in annual domestic revenue and $200 million in export revenue. Yet, the insurance market is described as limited, leaving a substantial gap in coverage. This situation is a cause for concern, especially as the Insurance Council of New Zealand has not issued specific guidance on avian influenza risks.
A Broader Perspective
The detection of H5N1 in New Zealand's wild bird population serves as a reminder of the interconnectedness of global health and economic systems. The potential impact on the poultry industry, food manufacturing, retail logistics, and hospitality sectors highlights the far-reaching consequences of such an outbreak. It also raises questions about the preparedness and resilience of industries and governments in the face of emerging risks.
In conclusion, the H5N1 detection has exposed a critical gap in insurance coverage, leaving consequential losses unprotected. This issue, combined with regulatory changes and a tightening insurance market, presents a complex challenge for the poultry industry in New Zealand. It serves as a wake-up call for the insurance industry and government bodies to address biosecurity risks more comprehensively and proactively.
